Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 12/18/25
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor ConferenceBusiness Wire • 12/04/25
BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?Zacks Investment Research • 11/24/25
Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And ExitsSeeking Alpha • 11/20/25
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve DiseaseBusiness Wire • 11/09/25
Demographic Megatrend: Stocks Poised to Benefit From Global AgingZacks Investment Research • 10/31/25
Edwards Lifesciences (EW) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 10/30/25
Exploring Analyst Estimates for Edwards Lifesciences (EW) Q3 Earnings, Beyond Revenue and EPSZacks Investment Research • 10/28/25
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EWGlobeNewsWire • 10/28/25
Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025Business Wire • 10/27/25
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025Business Wire • 10/27/25
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EWPRNewsWire • 10/22/25
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EWBusiness Wire • 10/16/25
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewsWire • 10/06/25